International consensus statement on allergy and rhinology: rhinosinusitis 2021.

Abstract

I.

EXECUTIVE SUMMARY:

BACKGROUND: The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR-RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR-RS-2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence-based findings of the document.

METHODS:

ICAR-RS presents over 180 topics in the forms of evidence-based reviews with recommendations (EBRRs), evidence-based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary.

RESULTS:

ICAR-RS-2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence-based management algorithm is provided.

CONCLUSION:

This ICAR-RS-2021 executive summary provides a compilation of the evidence-based recommendations for medical and surgical treatment of the most common forms of RS.

• Authors: Richard R Orlandi, Todd T Kingdom, Timothy L Smith, Benjamin Bleier, Adam DeConde, Amber U Luong, David M Poetker, Zachary Soler, Kevin C Welch, Sarah K Wise, Nithin Adappa, Jeremiah A Alt, Wilma Terezinha Anselmo-Lima, Claus Bachert, Fuad M Baroody, Pete S Batra, Manuel Bernal-Sprekelsen, Daniel Beswick, Neil Bhattacharyya, Rakesh K Chandra, Eugene H Chang, Alexander Chiu, Naweed Chowdhury, Martin J Citardi, Noam A Cohen, David B Conley, John DelGaudio, Martin Desrosiers, Richard Douglas, Jean Anderson Eloy, Wytske J Fokkens, Stacey T Gray, David A Gudis, Daniel L Hamilos, Joseph K Han, Richard Harvey, Peter Hellings, Eric H Holbrook, Claire Hopkins, Peter Hwang, Amin R Javer, Rong-San Jiang, David Kennedy, Robert Kern, Tanya Laidlaw, Devyani Lal, Andrew Lane, Heung-Man Lee, Jivianne T Lee, Joshua M Levy, Sandra Y Lin, Valerie Lund, Kevin C McMains, Ralph Metson, Joaquim Mullol, Robert Naclerio, Gretchen Oakley, Nobuyoshi Otori, James N Palmer, Sanjay R Parikh, Desiderio Passali, Zara Patel, Anju Peters, Carl Philpott, Alkis J Psaltis, Vijay R Ramakrishnan, Murugappan Ramanathan Jr, Hwan-Jung Roh, Luke Rudmik, Raymond Sacks, Rodney J Schlosser, Ahmad R Sedaghat, Brent A Senior, Raj Sindwani, Kristine Smith, Kornkiat Snidvongs, Michael Stewart, Jeffrey D Suh, Bruce K Tan, Justin H Turner, Cornelis M van Drunen, Richard Voegels, De Yun Wang, Bradford A Woodworth, Peter-John Wormald, Erin D Wright, Carol Yan, Luo Zhang, Bing Zhou
• Journal: International forum of allergy & rhinology (Int Forum Allergy Rhinol) Vol. 11 Issue 3 Pg. 213-739 (03 2021) ISSN: 2042-6984 [Electronic] United States
• PMID: 33236525 (Publication Type: Journal Article, Review)
• Copyright: © 2021 ARS-AAOA, LLC.

Topics

• Consensus
• Humans
• Rhinitis (therapy)
• Rhinitis, Allergic
• Sinusitis (therapy)